Benjamin Landry is CLO at Health Catalyst, Inc. (HCAT). They have made 1 open-market trade across 1 company since 2023, most recently 2026-09-01.
CIK 0001975281
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HCAT | 351,372 | $608K |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCAT | SELL · 10b5-1 | 2025-12-05 | 2025-12-09 | $2.64 | $72K | -9.3% | -5.4% | -26.3% |
| HCAT | SELL · 10b5-1 | 2025-09-05 | 2025-09-09 | $3.35 | $21K | -14.5% | -17.8% | -21.9% |
| HCAT | SELL · 10b5-1 | 2025-06-05 | 2025-06-09 | $3.94 | $24K | -13.7% | -3.4% | -18.9% |
| HCAT | SELL · 10b5-1 | 2025-03-06 | 2025-03-10 | $4.55 | $126K | +8.0% | +0.2% | +3.7% |
| HCAT | SELL · 10b5-1 | 2025-01-06 | 2025-01-10 | $7.52 | $19K | -15.0% | -15.6% | -43.8% |
| HCAT | SELL · 10b5-1 | 2024-12-06 | 2024-12-10 | $8.32 | $321K | -16.0% | -18.4% | -53.0% |
| HCAT | SELL · 10b5-1 | 2024-09-06 | 2024-09-10 | $7.39 | $18K | +12.3% | +1.4% | +7.8% |
| HCAT | SELL · 10b5-1 | 2024-06-06 | 2024-06-12 | $6.71 | $16K | -8.6% | -2.3% | +18.6% |
| HCAT | SELL | 2024-05-31 | 2024-06-04 | $6.61 | $166K | -2.9% | -6.9% | +9.0% |
| HCAT | SELL · 10b5-1 | 2023-09-06 | 2023-09-06 | $11.52 | $13K | -12.0% | -16.9% | -36.7% |
| HCAT | SELL · 10b5-1 | 2023-07-07 | 2023-07-11 | $11.14 | $13K | +2.7% | -1.0% | -22.2% |
| HCAT | SELL · 10b5-1 | 2023-06-06 | 2023-06-08 | $11.84 | $13K | +1.5% | +5.8% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.